Table of Contents Table of Contents
Previous Page  e139 860 Next Page
Information
Show Menu
Previous Page e139 860 Next Page
Page Background

Letter to the Editor

Re: Umberto Leone Roberti Maggiore, Simone Ferrero,

Massimo Candiani, et al. Bladder Endometriosis:

A Systematic Review of Pathogenesis, Diagnosis,

Treatment, Impact on Fertility, and Risk of Malignant

Transformation. Eur Urol 2017;71:790–807

Benign Mu¨llerian Lesions in the Urinary Bladder: Endome-

triosis, Endocervicosis, Endosalpingiosis, and Mu¨llerianosis

We read with interest the paper by Leone Roberti

Maggiore et al

[1]

published in a recent issue of

European

Urology

. The authors reviewed available knowledge on

bladder endometriosis (BE) and provided physicians with

guidance on the management of this condition. The authors

pointed out that ‘‘BE is defined as the presence of

endometrial glands and stroma in the detrusor muscle’’

and ‘‘the potential risk of malignant transformation since

this phenomenon is exceedingly rare’’

[1]

.

1.

Bladder lesions comprising mu¨ llerian-derived

tissue

From a morphological point of view, BE is part of a wide

spectrum of lesions comprising mu¨ llerian-derived tissue.

Benign lesions include not only endometriosis but also

endocervicosis, endosalpingiosis, andmu¨ llerianosis

[2]

. These

lesions can involve all the components of the bladder wall,

from the mucosa to the serosa, and are typically centered in

the muscularis propria (detrusor). There are exceedingly rare

malignant mu¨ llerian lesions that can complicate a benign

mu¨ llerian lesion, such as BE. Potentially any formofmu¨ llerian

neoplasia that may complicate endometriosis, as observed

more commonly elsewhere, is a potential finding in the

urinary bladder, including mu¨ llerian-type clear cell carcino-

ma, endometrioid carcinoma, and mu¨ llerian adenosarcoma.

In addition, mu¨ llerian-like lesions can be observed in the

bladder, including a mu¨ llerian-like appearance in urothelial

neoplasia, urachal lesions with mu¨ llerian-like features, and

secondary mu¨ llerian neoplasia

[3]

.

2.

Endometriosis

The urinary bladder is involved in approximately 1% of

women with endometriosis. It is the most common location

of urinary tract involvement of this disease

[4,5]

. It can also

be seen in the ureter and less commonly in the urethra or

kidney

[6]

. Approximately 50% of these patients have a

previous history of pelvic surgery, such as cesarean section.

In up to 12% of cases there is no evidence of endometriosis

outside the bladder

[4,5]

. Rare cases of BE have been

observed in men with prostate adenocarcinoma treated

with estrogen therapy. The histological features of endo-

metriosis—endometrial glands and stroma

( Fig. 1 )

—are so

distinctive that confusion with other mu¨ llerian glandular

lesions should not be an issue. The glands are lined by

cuboidal cells with the same changes seen in the normal

endometrium, depending on the phase of the cycle,

including decidual reaction (ie, decidualized vesical endo-

metriosis) and Arias-Srella reaction. The endometriotic

stroma contains foamy histiocytes with hemosiderin and

inflammatory cells, or can show elastosis. Any of the

common to rare features of endometriosis observed

elsewhere can be seen in the bladder

[4,5]

.

Malignant tumors, in particular clear cell and endome-

trioid carcinoma, have arisen in association with BE

[4,5,7,8]

. In such cases the glands show typically a more

complex pattern and architecture, with crowding (back-to-

back glands without intervening stroma) and cribriform

growth. Cytological atypia is prominent. There is desmo-

plastic reaction, in contrast to the endometrial stroma seen

in BE. Clear cell carcinoma with glandular morphology can

mimic a very similar type occurring on a background of

urothelial carcinoma, a neoplasm that can have clear cells.

The presence of unequivocal urothelial carcinoma and

immunohistochemistry can have a role in the differential

diagnosis

[4,5]

.

3.

Endocervicosis

Endocervicosis, a benign glandular lesion, involves the

urinary bladder as well as the outer wall of the uterine

cervix, vagina, paracervical connective tissue, pelvic perito-

neum, and pelvic lymph nodes in female patients of

reproductive age

[4,5]

. The most common location of the

glands, which are irregular in shape and size, is the posterior

wall of the bladder, centered in the detrusor (muscularis

propria) with extension to the subepithelial connective

tissue and bladder serosa. The lesion is composed of glands

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) e 1 3 9 – e 1 4 1

ava ilable at

www.sciencedirect.com

journal homepage:

www.eu ropeanurology.com

DOI of original article:

http://dx.doi.org/10.1016/j.eururo.2016.12.015

.

http://dx.doi.org/10.1016/j.eururo.2017.05.029

0302-2838/

#

2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.